CNO — California Nanotechnologies Income Statement

0.000.00%

Last trade - 00:00

IndustrialsSpeculativeMicro CapHigh Flyer

Annual income statement for California Nanotechnologies, fiscal year end - February 29th, USD millions except per share, conversion factor applied.

	2020 February 29th	2021 February 28th	2022 February 28th	2023 February 28th	2024 February 29th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.831	0.795	1.08	1.38	3.34
Cost of Revenue
Gross Profit	0.523	0.46	0.757	0.998	2.33
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	0.818	0.916	0.872	1.19	2.7
Operating Profit	0.013	-0.122	0.21	0.189	0.635
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.058	-0.121	0.201	0.084	0.382
Provision for Income Taxes
Net Income After Taxes	-0.056	-0.121	0.201	0.08	0.382
Net Income Before Extraordinary Items
Net Income	-0.056	-0.121	0.201	0.08	0.382
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.056	-0.121	0.201	0.08	0.382
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.002	-0.003	0.006	0.002	0.01